A Clinical Trial of Metformin in the Maintenance of Non-Hodgkin's Lymphoma Patients
Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
The study is to evaluate the therapeutic effect of metformin as a maintenance therapy in high
risk patients with complete remission of diffuse large B lymphoma / stage III follicular
lymphoma after chemotherapy in the initial R-CHOP (cyclophosphamide, doxorubicin,
vincristine, and prednisone, plus the monoclonal antibody rituximab) regimen